High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy

Christopher C. Y. Wong; Austin C. C. Ng; Jerrett K. Lau; Vincent Chow; Vivien Chen; Arnold C. T. Ng; Andy S. C. Yong; Andrew P. Sindone; Thomas H. Marwick; Leonard Kritharides

doi:10.1160/TH15-11-0869

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2016; 115(06): 1191-1199
DOI: 10.1160/TH15-11-0869

Stroke, Systemic or Venous Thromboembolism

Schattauer GmbH

High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy

Christopher C. Y. Wong

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

,

Austin C. C. Ng

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

²Vascular Biology Group, ANZAC Research Institute, Concord, New South Wales, Australia

,

Jerrett K. Lau

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

²Vascular Biology Group, ANZAC Research Institute, Concord, New South Wales, Australia

,

Vincent Chow

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

²Vascular Biology Group, ANZAC Research Institute, Concord, New South Wales, Australia

,

Vivien Chen

²Vascular Biology Group, ANZAC Research Institute, Concord, New South Wales, Australia

³Department of Haematology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

,

Arnold C. T. Ng

⁴Department of Cardiology, Princess Alexandra Hospital, University of Queensland, St. Lucia, Queensland, Australia

,

Andy S. C. Yong

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

²Vascular Biology Group, ANZAC Research Institute, Concord, New South Wales, Australia

,

Andrew P. Sindone

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

,

Thomas H. Marwick

⁵Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia

,

Leonard Kritharides

¹Department of Cardiology, Concord Hospital, University of Sydney, Concord, New South Wales, Australia

²Vascular Biology Group, ANZAC Research Institute, Concord, New South Wales, Australia

› Institutsangaben

Abstract

Summary

The prognostic significance of patients presenting with pulmonary embolism (PE) and elevated International Normalised Ratio (INR) not on anticoagulant therapy has not been described. We investigated whether these patients had higher mortality compared to patients with normal INR. A retrospective study of patients admitted to a tertiary hospital with acute PE from 2000 to 2012 was undertaken, with study outcomes tracked using a state-wide death registry. Patients were excluded if they were taking anticoagulants or had inadequate documentation of their INR and medication status. Of the 1,039 patients identified, 94 (9 %) had an elevated INR (> 1.2) in the absence of anticoagulant use. These patients had higher mortality at six months follow-up (26 % vs 6 %, p< 0.001) compared to controls (INR ≤ 1.2). An INR > 1.2 at diagnosis was an independent predictor of death at six months post-PE (hazard ratio [HR] 2.9, 95 % confidence interval [CI] 1.8–4.7, p< 0.001). The addition of INR to a multivariable model that included the simplified pulmonary embolism severity index (sPESI), chest pain, and serum sodium led to a significant net reclassification improvement estimated at 8.1 %. The final model’s C statistic increased significantly by 0.04 (95 % CI 0.01–0.08, p=0.03) to 0.83 compared to sPESI alone (0.79). In summary, patients presenting with acute PE and elevated INR while not on anticoagulant therapy appear to be at high risk of death. Future validation studies in independent cohorts will clarify if this novel finding can be usefully incorporated into clinical decision making in patients with acute PE.

Keywords

International Normalised Ratio - anticoagulant - mortality - prognosis - pulmonary embolism

Volltext

Referenzen

References
1 White R. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-I8.
2 Goldhaber S, Visani L, Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
3 Laporte S, Mismetti P, Decousus H. et al. Clinical Predictors for Fatal Pulmonary Embolism in 15520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716.
4 Spencer F, Goldberg R, Lessard D. et al. Factors Associated With Adverse Outcomes in Outpatients Presenting With Pulmonary Embolism: The Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes 2010; 3: 390-394.
5 Heit J, Silverstein M, Mohr D. et al. Predictors of Survival After Deep Vein Thrombosis and Pulmonary Embolism. Arch Intern Med 1999; 159: 445-453.
6 Ng AC, Chung T, Yong AS. et al. Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Circ Cardiovasc Qual Outcomes 2011; 4: 122-128.
7 Riley R, Rowe D, Fisher L. Clinical Utilization of the International Normalized Ratio (INR). J Clin Lab Anal 2000; 14: 101-114.
8 Hirsh J, Poller L. The International Normalized Ratio: A Guide to Understanding and Correcting Its Problems. Arch Intern Med 1994; 154: 282-288.
9 Wiesner R, Edwards E, Freeman R. et al. Model for End-Stage Liver Disease (MELD) and Allocation of Donor Livers. Gastroenterology 2003; 124: 91-96.
10 Moutzouris JP, Ng AC, Chow V. et al. Acute pulmonary embolism during warfarin therapy and long-term risk of recurrent fatal pulmonary embolism. Thromb Haemost 2013; 110: 523-533.
11 Ng A, Chow V, Yong A. et al. Fluctuation of Serum Sodium and Its Impact on Short and Long-Term Mortality following Acute Pulmonary Embolism. PLoS One. 8. e61966.
12 Moutzouris J, Chow V, Yong A. et al. Acute Pulmonary Embolism in Individuals Aged 80 and Older. J Am Geriatr Soc 2014; 62: 2004-2006.
13 Torbicki A, Perrier A, Konstantinides S. et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008; 29: 2276-2315.
14 Jimenez D, Aujesky D, Moores L. et al. Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary Embolism. Arch Intern Med 2010; 170: 1383-1389.
15 Australian Bureau of Statistics. 2007 Available at http://www.abs.gov.au Accessed March, 2009.
16 National Center for Health Statistics. Instructions for Classifying the Underlying Cause-of-Death, ICD-10. 2008: 1-259 Available at http://www.cdc.gov/ nchs/about/major/dvs/im.htm Accessed June 10, 2009.
17 Peltan I, Vande V, Maier R. et al. An International Normalized Ratio-Based Definition of Acute Traumatic Coagulopathy Is Associated With Mortality, Venous Thromboembolism, and Multiple Organ Failure After Injury. Crit Care Med 2015; 43: 1429-1438.
18 Peugh J, Enders C. Missing data in educational research: A review of reporting practices and suggestions for improvement. Rev Educational Res 2004; 74: 525-556.
19 Harrell Jr FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
20 Newson RB. Comparing the predictive powers of survival models using Harrell’s C or Somers’ D. Stata J 2010; 10: 339-358.
21 Hosmer Jr DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989
22 Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB. et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172 discussion 207-212.
23 Scherz N, Labarere J, Mean M. et al. Prognostic Importance of Hyponatremia in Patients with Acute Pulmonary Embolism. Am J Respir Crit Care Med 2010; 182: 1178-1183.
24 Dabbagh O, Oza A, Prakash S. et al. Coagulopathy Does Not Protect Against Venous Thromboembolism in Hospitalized Patients With Chronic Liver Disease. Chest 2010; 137: 1145-1149.
25 Moller S, Bernadi M. Interactions of the heart and the liver. Eur Heart J 2013; 34: 2804-2811.
26 Lee A. Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev 2002; 28: 137-140.
27 Sato Y, Honda Y, Hayashida N. et al. Vitamin K Deficiency and Osteopenia in Elderly Women With Alzheimer’s Disease. Arch Phys Med Rehabil 2005; 86: 576-581.
28 Galli M, Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 1999; 93: 2149-2157.
29 Leitner J, Jilma B, Spiel A. et al. Massive pulmonary embolism leading to cardiac arrest isassociated with consumptive coagulopathy presenting as disseminated intravascular coagulation. J Thromb Haemost 2010; 8: 1477-1482.
30 Stahl R, Javid J, Lackner H. Unrecognized Pulmonary Embolism Presenting as Disseminated Intravascular Coagulation. Am J Med 1984; 76: 772-778.
31 Pesola G, Carlon G. Pulmonary embolus-induced disseminated intravascular coagulation. Crit Care Med 1987; 15: 983-984.

Zusatzmaterial

Zusatzmaterial